{"id":58878,"date":"2024-08-30T12:04:29","date_gmt":"2024-08-30T12:04:29","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/08\/30\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/"},"modified":"2024-08-30T12:04:29","modified_gmt":"2024-08-30T12:04:29","slug":"newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/","title":{"rendered":"NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September"},"content":{"rendered":"<div>\n<p align=\"left\">NAARDEN, The Netherlands and MIAMI, Aug.  30, 2024  (GLOBE NEWSWIRE) &#8212; NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or \u201cNewAmsterdam\u201d or the \u201cCompany\u201d), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (\u201cCVD\u201d) with elevated low-density lipoprotein cholesterol (\u201cLDL-C\u201d), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that company management will participate in the following upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li><strong>Morgan Stanley 22<\/strong><sup><strong>nd<\/strong><\/sup><strong> Annual Global Healthcare Conference<\/strong> in New York City, NY. Company management will host 1&#215;1 meetings on Thursday, September 5, 2024, and Ian Somaiya, Chief Financial Officer, will participate in a fireside chat on Friday, September 6, 2024, at 10:00 a.m. ET; and<\/li>\n<li><strong>Cantor Global Healthcare Conference<\/strong> in New York City, NY on Tuesday, September 17, 2024. Michael Davidson, M.D., Chief Executive Officer, and Ian Somaiya, Chief Financial Officer, will participate in a fireside chat at 3:40 p.m. ET.<\/li>\n<\/ul>\n<p>Live webcasts of both presentations will be available through the investor relations section of the NewAmsterdam Pharma website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yMyzF6gOwMY7ptlQghXsv3GP0K3h8u3nYRTUZWTTRJJUGZgUZYuMWhS8w52gQGoR6CTjFOkofZL2D14HvVt9S8mQ4ryH3JKaN9D2-ZYnT4Vo_XAxLC6mnpGOjKSVA3nY\" rel=\"nofollow noopener\" target=\"_blank\" title=\"ir.newamsterdampharma.com\">ir.newamsterdampharma.com<\/a>. Following the live webcast, an archived replay will be available on the Company\u2019s website.<\/p>\n<p><strong>About NewAmsterdam<\/strong><\/p>\n<p>NewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, well-tolerated and convenient LDL-lowering therapy. In multiple phase 3 studies, NewAmsterdam is investigating obicetrapib, an oral, low-dose and once-daily CETP inhibitor, alone or as a fixed-dose combination with ezetimibe, as LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of CVD with elevated LDL-C, for whom existing therapies are not sufficiently effective or well tolerated.<\/p>\n<p><strong>Company Contact<br \/><\/strong>Matthew Philippe<br \/>P: 1-917-882-7512<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9g910qCj9DC3r84JBess7nnT20JtoTsa8yAxgK9RHn8INDmM8G3_hyA8ZgKzy8mydOPhanLabcVKmOPPSi7wF1EDtY4yv0mp2N4Ok8ULMcImGtuqyp8DcW68Ndm6suACqsPLEHLeVQZ8qWhEWVbViA==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"matthew.philippe@newamsterdampharma.com\">matthew.philippe@newamsterdampharma.com<\/a><\/p>\n<p><strong>Media Contact<br \/><\/strong>Spectrum Science on behalf of NewAmsterdam<br \/>Bryan Blatstein<br \/>P: 1-917-714-2609<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tfzLten4YCR85IhoemPV1Ni9ScCL-QKch3QiVg0kUxqHxZQJeLj9q3S1w8T8x4VE4T44jzYweLjoliMdY6vpiSxXNoNXlJrwXCOKa5PTtuzZRpIFstwfAKCmnS8nXEB_\" rel=\"nofollow noopener\" target=\"_blank\" title=\"bblatstein@spectrumscience.com\">bblatstein@spectrumscience.com<\/a><\/p>\n<p><strong>Investor Contact<br \/><\/strong>Precision AQ on behalf of NewAmsterdam<br \/>Austin Murtagh<br \/>P: 1-212-698-8696<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5x7_2MjHx3HzCkbj1z9I6FJI74wqtRA7Xi_FP7_2YtNsSvAvQTsAoSMt6_G6YTzwOAfuRvRbbbhF5d4WvdwCZ7EekvgSMX2MJi7_FA6PcP8Gox0eLDcy6dTmB5tyDfGf\" rel=\"nofollow noopener\" target=\"_blank\" title=\"austin.murtagh@precisionaq.com\">austin.murtagh@precisionaq.com<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YWI3NmI0NmQtYWI3Ny00NjBhLTgyZDItZWM5MjMwYTIyZWUxLTEyNjE4OTQ=\/tiny\/NewAmsterdam-Pharma-N-V-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NAARDEN, The Netherlands and MIAMI, Aug. 30, 2024 (GLOBE NEWSWIRE) &#8212; NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or \u201cNewAmsterdam\u201d or the \u201cCompany\u201d), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (\u201cCVD\u201d) with elevated low-density lipoprotein cholesterol (\u201cLDL-C\u201d), for whom existing therapies are not sufficiently effective or well-tolerated, [&#8230;]\n","protected":false},"author":1,"featured_media":58879,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-58878","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September\" \/>\n<meta property=\"og:description\" content=\"NAARDEN, The Netherlands and MIAMI, Aug. 30, 2024 (GLOBE NEWSWIRE) &#8212; NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or \u201cNewAmsterdam\u201d or the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-30T12:04:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/08\/NewAmsterdam-Pharma-N-V-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September\",\"datePublished\":\"2024-08-30T12:04:29+00:00\",\"dateModified\":\"2024-08-30T12:04:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/\"},\"wordCount\":338,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/\",\"name\":\"NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-08-30T12:04:29+00:00\",\"dateModified\":\"2024-08-30T12:04:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September","og_description":"NAARDEN, The Netherlands and MIAMI, Aug. 30, 2024 (GLOBE NEWSWIRE) &#8212; NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or \u201cNewAmsterdam\u201d or the","og_url":"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-08-30T12:04:29+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/08\/NewAmsterdam-Pharma-N-V-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September","datePublished":"2024-08-30T12:04:29+00:00","dateModified":"2024-08-30T12:04:29+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/"},"wordCount":338,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/","url":"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/","name":"NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-08-30T12:04:29+00:00","dateModified":"2024-08-30T12:04:29+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/newamsterdam-pharma-to-participate-in-upcoming-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/58878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=58878"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/58878\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/58879"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=58878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=58878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=58878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}